Citius Pharmaceuticals Inc vs Gemini Space Station Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Gemini Space Station Inc trades at $4.02 (market cap $512.05M). The key difference: Gemini Space Station Inc is far larger — about 25.6× Citius Pharmaceuticals Inc's market cap, and Citius Pharmaceuticals Inc is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | GEMI | |
|---|---|---|
Market Cap | $20.01M | $512.05M |
Sector | Health | Technology |
52-Week High | $1.82 | $32.52 |
52-Week Low | $0.48 | $3.90 |
Enterprise Value | $16.23M | $502.04M |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →